Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Decitabine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04953910
What this trial is testing

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Taiho Oncology, Inc. 27
Early research (Phase 1)Study completedNCT00538876
What this trial is testing

Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML

Who this might be right for
Acute Myeloid Leukemia
Weill Medical College of Cornell University 30
Testing effectiveness (Phase 2)Study completedNCT02878785
What this trial is testing

Decitabine and Talazoparib in Untreated AML and R/R AML

Who this might be right for
Acute Myeloid Leukemia
University of Maryland, Baltimore 25
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04697940
What this trial is testing

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

Who this might be right for
Relapsed and Refractory B-cell Non-Hodgkin's LymphomaDecitabine-primed Tandem CD19/CD20 CAR T Cells
Han weidong 33
Testing effectiveness (Phase 2)Study completedNCT02441803
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05201066
What this trial is testing

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Novartis Pharmaceuticals 33
Large-scale testing (Phase 3)Not Yet RecruitingNCT06297772
What this trial is testing

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Who this might be right for
AML, Adult
Ruijin Hospital 220
Not applicableLooking for participantsNCT07420790
What this trial is testing

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Who this might be right for
Acute Myeloid Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941
Testing effectiveness (Phase 2)Ended earlyNCT01177540
What this trial is testing

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Who this might be right for
Pediatric Acute Myelogenous Leukemia (AML)
Eisai Inc. 25
Not applicableEnded earlyNCT01882660
What this trial is testing

Pre-operative Decitabine in Colon Cancer: a Proof of Principle Study

Who this might be right for
Colon Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 10
Testing effectiveness (Phase 2)Study completedNCT02197676
What this trial is testing

A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to Azacitidine or Decitabine After at Least 6 Courses or Relapsing After a Response

Who this might be right for
MDS
Groupe Francophone des Myelodysplasies 56
Very early researchStudy completedNCT03445858
What this trial is testing

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

Who this might be right for
Childhood Solid TumorChildhood LymphomaRelapsed Cancer+3 more
Children's Hospital Medical Center, Cincinnati 22
Testing effectiveness (Phase 2)Ended earlyNCT02029417
What this trial is testing

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
Roswell Park Cancer Institute 2
Testing effectiveness (Phase 2)UnknownNCT03467178
What this trial is testing

Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.

Who this might be right for
Recurrent, Platinum-resistant Ovarian Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 119
Large-scale testing (Phase 3)Study completedNCT00260832
What this trial is testing

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Eisai Inc. 485
Testing effectiveness (Phase 2)UnknownNCT03381781
What this trial is testing

Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations

Who this might be right for
Acute Myeloid LeukemiaP53 Mutation
Li Junmin 100
Testing effectiveness (Phase 2)UnknownNCT03701451
What this trial is testing

Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 30
Testing effectiveness (Phase 2)Study completedNCT03663751
What this trial is testing

Low-dose Decitabine for the Treatment of Decreased Donor Chimerism After Allogeneic Stem Cell Transplantation

Who this might be right for
Response Rate
Shanghai Jiao Tong University School of Medicine 14
Post-approval studies (Phase 4)UnknownNCT02013102
What this trial is testing

A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Cttq 240
Next Page